ARM CFO Jason Child sells 31,920 shares ($7.2M) under scheduled 10b5-1 plan; stock up +69.9% in 30 days, +137.5% in 90 days
Jason Child executed a scheduled sale of 31,920 shares at $226.54 under a 10b5-1 trading plan adopted on 2025-05-30, reducing his ARM holdings by 15.5% to 174,232 shares. The sale occurred as the stock has appreciated significantly, with a 30-day return of +69.9% and 90-day return of +137.5% from the transaction date. His prior two sales at ARM produced 30-day returns of +42.6% and +58.3% respectively, while his cross-ticker track record across 2 prior sales averaged +50.4% (30-day) and +57.8% (90-day). Because this transaction is part of a pre-arranged trading plan, it reflects scheduled execution rather than a discretionary trading decision tied to current market conditions or valuation views.
CFO Jason Child sold 21,280 ARM shares at $180.00 on 2026-04-22, retaining 153,426 shares post-transaction.
CFO Jason Child executed an open-market sale of 21,280 shares at $180.00 on 2026-04-22, reducing his position by 12.2% from 174,706 shares to 153,426 shares. ARM traded at $204.61 on the analysis date, up 51.6% over the prior 30 days and 76.3% over 90 days—meaning the stock appreciated significantly after this sale, suggesting the transaction was not well-timed from a price perspective. His cross-ticker track record shows only 1 prior sell transaction, providing minimal historical context for evaluating this insider's typical transaction patterns. The recent ARM position reduction follows another sell on 2026-03-25, indicating consecutive selling activity at the same ticker within approximately four weeks.
ARM CFO Jason Child sold 21,280 shares ($3.2M) at $148.37; stock now $144.13, -19.3% from 52-week high
CFO Jason Child sold 21,280 shares at $148.37 on 2026-03-25, reducing holdings from 195,986 to 174,706 shares (-10.9%). The sale occurred near the upper end of ARM's 52-week range ($85.82–$178.62), with the stock currently trading at $144.13, 19.3% below its 52-week high. The timing coincides with strong recent momentum: ARM has rallied 9.4% over 30 days and 30.7% over 90 days. With a $152.3B market cap, this remains a substantial insider stake at 174.7K shares post-transaction. Investors should track whether this sale reflects portfolio rebalancing at an elevated price level or signals management views on valuation after the recent momentum surge.
